|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Peculiarities of chronic heart failure in COPD patients
|
№5 / 2019
|
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|
|
Ju.V. Lukina
Atherosclerosis and comorbidity
|
№4 / 2018
|
|
E.V. Nadei, V.I. Sovalkin, G.I. Nechaeva, D.V. Turchaninov
Feasibility of achieving control of comorbid atopic bronchial asthma
|
№3 / 2018
|
|
Ye.I. Tarlovskaya
Problem of polymorbidity – challenge tо modern medicine
|
№2 / 2017
|
|
A.N. Kuznetsov, N.Yu. Grigorieva, T.P. Ilyushina, M.B. Mayorova
Is there a relationship between bronchial asthma and arterial hypertension?
|
№1 / 2017
|
|
T.V. Adasheva, A.G. Malyavin, A.I. Martynov
Expert support for medical decisions in rational use of medicines in the context of polymorbidity
|
№6 / 2016
|
|
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
|
№5 / 2016
|
|
N.Yu. Grigorieva, A.N. Kuznetsov
Arterial hypertension and chronic bronchopulmonary diseases
|
№3 / 2016
|
|
G.L. Yurenev, A.N. Kazyulin, T.V. Yureneva-Tkhorzhevskaya
The influence of acid-suppressive therapy on the clinical course of ischemic heart disease with refractory pain syndrome in the chest
|
№2 / 2015
|
|
V.B. Mychka, E.I. Uzueva
Cardiovascular diseases at the prehospital stage: how to improve the effectiveness of care?
|
№1 / 2015
|
Русский
